ferric chloride has been researched along with Anti-Phospholipid Antibody Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammollo, CT; Argenziano, M; Capolla, S; Cavalli, R; Colucci, M; Di Leonardo, V; Durigutto, P; Macor, P; Marchbank, K; Meroni, P; Semeraro, F; Smith-Jackson, K; Tedesco, F; Tolva, VS | 1 |
| Kong, X; Sheng, L; Wang, T; Xia, L; Xie, H; Xie, Y; Yan, J; Zhou, H | 1 |
2 other study(ies) available for ferric chloride and Anti-Phospholipid Antibody Syndrome
| Article | Year |
|---|---|
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy.
Topics: Animals; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Endothelial Cells; Fibrinolytic Agents; Mice; Rats; Thromboembolism; Thrombosis; Tissue Plasminogen Activator | 2023 |
TLR4 is involved in the pathogenic effects observed in a murine model of antiphospholipid syndrome.
Topics: Animals; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; beta 2-Glycoprotein I; Carotid Artery Thrombosis; Cell Adhesion; Chlorides; Disease Models, Animal; E-Selectin; Femoral Vein; Ferric Compounds; Immunoglobulin G; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Mice; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Venous Thrombosis | 2015 |